Co announces it launched Amlodipine Besylate Tablets, 2.5 mg, 5 mg and 10 mg. Amlodipine Besylate Tablets are the generic version of Pfizer's Norvasc Tablets, which had U.S. sales of approximately ...

This study evaluates the pharmacokinetics and bioequivalence of Amlodipine Besylate Tablets 5 mg versus Norvasc 5 mg tablets administered as 5 mg tablet in healthy volunteers with a washout period of ...

Co announces that the U.S. Food and Drug Administration has granted approval for the co's ANDA for Amlodipine Besylate Tablets, 2.5 mg, 5 mg and 10 mg. Shipment of the product will begin shortly. TEVA ...

Nov. 11, 2005 — The U.S. Food and Drug Administration (FDA) has approved first-time generic formulations of glimepiride 1-, 2-, and 4-mg tablets and first-time doses of 3-, 6-, and 8-mg tablets for ...

January 27, 2007 —The European Commission has approved valsartan plus amlodipine besylate tablets for the treatment of hypertension in patients who do not achieve adequate blood pressure control with ...

Ranbaxy Pharmaceuticals Inc. said today that it has received tentative approval from the U.S. Food and Drug Administration to make and sell three doses of amlodipine besylate tablets, a generic ...